Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Beginning Cash Balance: 2020-2024

Historic Beginning Cash Balance for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $189.5 million.

  • Cellebrite DI's Beginning Cash Balance rose 67.57% to $179.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $614.2 million, marking a year-over-year increase of 12.89%. This contributed to the annual value of $189.5 million for FY2024, which is 116.23% up from last year.
  • Cellebrite DI's Beginning Cash Balance amounted to $189.5 million in FY2024, which was up 116.23% from $87.6 million recorded in FY2023.
  • Cellebrite DI's Beginning Cash Balance's 5-year high stood at $189.5 million during FY2024, with a 5-year trough of $81.7 million in FY2020.
  • Its 3-year average for Beginning Cash Balance is $141.0 million, with a median of $146.0 million in 2022.
  • As far as peak fluctuations go, Cellebrite DI's Beginning Cash Balance crashed by 39.96% in 2023, and later skyrocketed by 116.23% in 2024.
  • Yearly analysis of 5 years shows Cellebrite DI's Beginning Cash Balance stood at $81.7 million in 2020, then surged by 63.86% to $133.8 million in 2021, then increased by 9.06% to $146.0 million in 2022, then slumped by 39.96% to $87.6 million in 2023, then surged by 116.23% to $189.5 million in 2024.